Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
NCT05851378
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Adult Gliomas, Mixed
Interventions
DRUG:
Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
PROCEDURE:
Magnetic Resonance Image (MRI)
Sponsor
Robert Bok, MD, PhD
Collaborators
[object Object]